Standort: ---
Exemplare:
---
| |  Online-Ressource |
|---|
| Verfasst von: | Hoffmann, Jochen [VerfasserIn]  |
|---|
| | Knoop, Christian [VerfasserIn] |
|---|
| | Schäkel, Knut [VerfasserIn] |
|---|
| | Enk, Alexander [VerfasserIn] |
|---|
| | Hadaschik, Eva [VerfasserIn] |
|---|
| Titel: | Long-term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)-α antagonists versus TNF-α antagonists alone in psoriatic patients |
|---|
| Verf.angabe: | Jochen H.O. Hoffmann, Christian Knoop, Kunt Schäkel, Alexander H. Enk, Eva N. Hadaschik |
|---|
| Jahr: | 2021 |
|---|
| Umfang: | 9 S. |
|---|
| Fussnoten: | First published: 20 January 2021 ; Gesehen am 14.09.2021 |
|---|
| Titel Quelle: | Enthalten in: The journal of dermatology |
|---|
| Ort Quelle: | Oxford [u.a.] : Wiley-Blackwell, 1974 |
|---|
| Jahr Quelle: | 2021 |
|---|
| Band/Heft Quelle: | 48(2021), 6, Seite 835-843 |
|---|
| ISSN Quelle: | 1346-8138 |
|---|
| Abstract: | Methotrexate, a folic acid analog, is the conventional systemic anti-psoriatic agent most commonly chosen for combination with biologics in the treatment of psoriasis. Real-world long-term safety data of this combination versus biologic treatment alone in dermatological practice are sparse. |
|---|
| DOI: | doi:10.1111/1346-8138.15754 |
|---|
| URL: | Volltext ; Verlag: https://doi.org/10.1111/1346-8138.15754 |
|---|
| | Volltext: https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.15754 |
|---|
| | DOI: https://doi.org/10.1111/1346-8138.15754 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| K10plus-PPN: | 1770301755 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
| |
|
|---|
| | |
|---|
| Lokale URL UB: |  Zum Volltext |
|---|
Long-term safety of combination treatment with methotrexate and tumor necrosis factor (TNF)-α antagonists versus TNF-α antagonists alone in psoriatic patients / Hoffmann, Jochen [VerfasserIn]; 2021 (Online-Ressource)
68779187
